estalis continuous
sandoz new zealand limited - estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours; ; norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours; - transdermal patch - 50/140 - active: estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive - treatment of symptoms of oestrogen deficiency in postmenopausal women with an intact uterus. prevention of osteoporosis in postmenopausal women with an intact uterus.
estalis continuous
sandoz new zealand limited - estradiol hemihydrate 0.512mg equivalent to oestradiol 50 µg/24 hours; ; norethisterone acetate 4.8mg equivalent to norethisterone acetate 250 µg/24 hours; - transdermal patch - 50/250 - active: estradiol hemihydrate 0.512mg equivalent to oestradiol 50 µg/24 hours norethisterone acetate 4.8mg equivalent to norethisterone acetate 250 µg/24 hours excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive - treatment of symptoms of oestrogen deficiency in postmenopausal women with an intact uterus. prevention of osteoporosis in postmenopausal women with an intact uterus.
kliovance
novo nordisk pharmaceuticals ltd - estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol; ; ; ; norethisterone acetate 0.5mg; ; ; - film coated tablet - active: estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol norethisterone acetate 0.5mg excipient: copovidone hypromellose lactose monohydrate magnesium stearate maize starch purified talc triacetin
estalis continuous
novartis pharmaceuticals australia pty ltd - norethisterone acetate; oestradiol -
estalis sequi
novartis new zealand ltd - estradiol 4.33mg equivalent to 50 µg/24h oestradiol; estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours; ; norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours; - transdermal patch - 50 + 50/140 - active: estradiol 4.33mg equivalent to 50 µg/24h oestradiol excipient: 1,3-butylene glycol acrylic adhesive bentonite dipropylene glycol ethylenevinylacetate copolymer lecithin liquid paraffin oleic acid polyisobutylene synthetic adhesive active: estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive
estalis sequi
novartis new zealand ltd - estradiol hemihydrate 4.33mg equivalent to oestradiol 50 µg/24 hours; ; estradiol hemihydrate 0.512mg equivalent to oestradiol 50 µg/24 hours; norethisterone acetate 4.8mg equivalent to norethisterone acetate 250 µg/24 hours; - transdermal patch - 50 + 50/250 - active: estradiol hemihydrate 4.33mg equivalent to oestradiol 50 µg/24 hours excipient: 1,3-butylene glycol acrylic adhesive bentonite dipropylene glycol ethylenevinylacetate copolymer lecithin liquid paraffin oleic acid polyisobutylene synthetic adhesive active: estradiol hemihydrate 0.512mg equivalent to oestradiol 50 µg/24 hours norethisterone acetate 4.8mg equivalent to norethisterone acetate 250 µg/24 hours excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive - prevention of osteoporosis in postmenopausal women with an intact uterus.
evorel conti
janssen-cilag ltd - norethisterone acetate ; estradiol hemihydrate - transdermal patch - 50/170 microgram - estradiol, combinations
norethisterone 5mg tablets
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - norethisterone - tablet - norethisterone 5 mg - endocrine therapy
kliogest
novo nordisk pharmaceuticals pty ltd - oestradiol hemihydrate; norethisterone acetate; oestradiol -
kliovance
novo nordisk pharmaceuticals pty ltd - norethisterone acetate; oestradiol hemihydrate; oestradiol -